Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chylobinoid Topical Cream for Restless Leg Syndrome
NCT06570941Phase 2Active, not recruiting
- Sponsor
- Synthonics, Inc.
- Start
- Mar 2024
- Primary completion
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Chylobinoid in restless legs syndrome (RLS), sponsored by Synthonics, Inc.. Started Mar 2024; status: active, not recruiting.
02
Drugs
Chylobinoid
03
Conditions
restless legs syndrome (RLS)
Beyond the preview
Go deeper on NCT06570941.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06570941.